Skip to content
Home/Companies/Biotech/ArsenalBio
AR

ArsenalBio

Biotech·United States·Active·4yr hold

ArsenalBio is a biotech company, headquartered in United States.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns ArsenalBio?

ArsenalBio is currently owned by Hitachi Ventures through Hitachi Ventures Fund II (2021 vintage), since 2022.

Hand-verified · updated 2026-07-03

Hitachi Ventures
Investor
Hitachi Ventures
Hitachi Ventures Fund II · 2021 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Hitachi Ventures Fund II

Other portfolio companies in the same fund.

Ascend Elements
Active
EnergyUnited States· 2022
BeZero Carbon
Active
ClimateTechUnited Kingdom· 2022
Makersite
Active
SaaSGermany· 2022
Proscia
Active
MedTechUnited States· 2022
Scipher Medicine
Active
HealthTechUnited States· 2022
Weka
Active
SoftwareUnited States· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings